Clinical Trials Update: April 21, 2008
-- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This clinical trial will evaluate a study drug in people with atherosclerotic disease. To qualify, you must be at least 18 and have a history of atherosclerosis involving the coronary, cerebral, or peripheral vascular systems.
The research site is in New Hyde Park, N.Y.
This is a phase-2 study designed to evaluate the safety and effectiveness of NKTR-102 (PEG-irinotecan) to treat colorectal cancer.
The research site is in Dallas, Texas.
This study will evaluate lacosamide monotherapy in people with partial-onset seizures who have stopped using one or two marketed antiepileptic drugs. Candidates must be diagnosed with epilepsy with simple partial seizures (motor component) and/or complex partial seizures, and must be experiencing two to 40 seizures per 28-day period.
The research site is in Edison, NJ.
Copyright 2008 CenterWatch. All rights reserved.
Posted: April 2008